Diseases, Conditions, Syndromes

Clinical trial demonstrates success in treating rare blood disorder

A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than one in 5,000 people worldwide.

page 1 from 19